InsiderClue
Insiders · Profile

UBBEN JEFFREY W

Director at AES · Director at Willis Towers Watson · Director at Bausch Health Companies. Filing since 28 Feb 2014. CIK 0001159187

AES AES Corporation Director · 6 trades WTW Willis Towers Watson Director · 41 trades BHC Bausch Health Companies Inc. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AES AES Corporation
11 Jun 2020
Director
Bought
500,000
$6.11M
10.3%
AES AES Corporation
15 May 2020
Director
Bought
500,000
$5.84M
11.5%
AES AES Corporation
12 Aug 2019
Director
Bought
200,000
$3.05M
4.8%
AES AES Corporation
13 May 2019
Director
Bought
100,000
$1.60M
2.5%
AES AES Corporation
9 May 2019
Director
Bought
2,482,000
$39.99M
159%
AES AES Corporation
26 Dec 2018
Director
Bought
35,000
$481.25K
2.3%
WTW Willis Towers Watson
10 Nov 2017
Director
Sold, plan not stated
120,000
$19.37M
5.1%
WTW Willis Towers Watson
9 Nov 2017
Director
Sold, plan not stated
320,000
$51.57M
11.9%
WTW Willis Towers Watson
13 Oct 2017
Director
Sold, plan not stated
128,237
$20.18M
4.6%
WTW Willis Towers Watson
12 Oct 2017
Director
Sold, plan not stated
103,578
$16.20M
3.6%
WTW Willis Towers Watson
11 Oct 2017
Director
Sold, plan not stated
55,717
$8.69M
1.9%
WTW Willis Towers Watson
6 Oct 2017
Director
Sold, plan not stated
8,118
$1.27M
0.3%
WTW Willis Towers Watson
27 Sep 2017
Director
Sold, plan not stated
1,200
$187.21K
0.0%
WTW Willis Towers Watson
26 Sep 2017
Director
Sold, plan not stated
303,150
$46.95M
9.2%
WTW Willis Towers Watson
18 Sep 2017
Director
Sold, plan not stated
41,348
$6.30M
1.2%
WTW Willis Towers Watson
12 Sep 2017
Director
Sold, plan not stated
138,806
$21.15M
4.0%
WTW Willis Towers Watson
11 Sep 2017
Director
Sold, plan not stated
54,194
$8.25M
1.5%
WTW Willis Towers Watson
8 Sep 2017
Director
Sold, plan not stated
65,652
$9.99M
1.8%
WTW Willis Towers Watson
7 Sep 2017
Director
Sold, plan not stated
220,000
$32.58M
5.8%
WTW Willis Towers Watson
6 Sep 2017
Director
Sold, plan not stated
206,000
$30.49M
5.1%
WTW Willis Towers Watson
5 Sep 2017
Director
Sold, plan not stated
33,000
$4.88M
0.8%
WTW Willis Towers Watson
1 Sep 2017
Director
Sold, plan not stated
120,000
$17.86M
2.9%
WTW Willis Towers Watson
31 Aug 2017
Director
Sold, plan not stated
63,000
$9.36M
1.5%
WTW Willis Towers Watson
28 Aug 2017
Director
Sold, plan not stated
1,000
$149.00K
0.0%
WTW Willis Towers Watson
25 Aug 2017
Director
Sold, plan not stated
310,000
$46.20M
6.8%
WTW Willis Towers Watson
24 Aug 2017
Director
Sold, plan not stated
10,000
$1.49M
0.2%
WTW Willis Towers Watson
23 Aug 2017
Director
Sold, plan not stated
160,000
$23.84M
3.4%
WTW Willis Towers Watson
22 Aug 2017
Director
Sold, plan not stated
480,000
$71.75M
9.3%
WTW Willis Towers Watson
21 Aug 2017
Director
Sold, plan not stated
65,000
$9.69M
1.2%
WTW Willis Towers Watson
18 Aug 2017
Director
Sold, plan not stated
36,000
$5.36M
0.7%
WTW Willis Towers Watson
17 Aug 2017
Director
Sold, plan not stated
5,000
$750.20K
0.1%
WTW Willis Towers Watson
16 Aug 2017
Director
Sold, plan not stated
211,000
$31.73M
3.8%
WTW Willis Towers Watson
15 Aug 2017
Director
Sold, plan not stated
105,000
$15.88M
1.9%
WTW Willis Towers Watson
11 Aug 2017
Director
Sold, plan not stated
60,000
$8.94M
1.1%
WTW Willis Towers Watson
10 Aug 2017
Director
Sold, plan not stated
120,000
$17.89M
2.1%
WTW Willis Towers Watson
9 Aug 2017
Director
Sold, plan not stated
615,000
$91.96M
9.6%
WTW Willis Towers Watson
8 Aug 2017
Director
Sold, plan not stated
120,000
$17.97M
1.8%
WTW Willis Towers Watson
7 Aug 2017
Director
Sold, plan not stated
85,000
$12.73M
1.3%
WTW Willis Towers Watson
31 May 2017
Director
Sold, plan not stated
55,000
$7.98M
0.8%
WTW Willis Towers Watson
30 May 2017
Director
Sold, plan not stated
125,000
$18.13M
1.8%
WTW Willis Towers Watson
26 May 2017
Director
Sold, plan not stated
205,000
$29.73M
2.9%
WTW Willis Towers Watson
25 May 2017
Director
Sold, plan not stated
115,000
$16.68M
1.6%
WTW Willis Towers Watson
19 May 2017
Director
Sold, plan not stated
200,000
$28.07M
2.7%
WTW Willis Towers Watson
18 May 2017
Director
Sold, plan not stated
400,000
$56.04M
5.2%
WTW Willis Towers Watson
17 May 2017
Director
Sold, plan not stated
400,000
$56.42M
4.9%
BHC Bausch Health Companies Inc.
10 Jun 2015
Director
Sold, plan not stated
4,200,000
$925.01M
79.9%
BHC Bausch Health Companies Inc.
10 Dec 2014
Director
Bought
50,000
$6.96M
0.3%
BHC Bausch Health Companies Inc.
9 Dec 2014
Director
Bought
200,000
$28.05M
1.1%
BHC Bausch Health Companies Inc.
24 Nov 2014
Director
Bought
210,000
$29.87M
1.2%
WTW Willis Towers Watson
3 Mar 2014
Director
Bought
127,000
$5.21M
0.7%
WTW Willis Towers Watson
28 Feb 2014
Director
Bought
80,900
$3.31M
0.4%
51 decisions on file.